ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconIcon FacebookIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Consumer Non-Durables

Rohto Pharmaceutical Co., Ltd.

  • 3,400.00 JPY
  • 0.00
  • 0.00%
  • Japan
    Dec 17, 2018
  • Ticker
    TKS(4527)
  • Prev. close
    3,400
  • Market cap (JPY)
    401,165.68M
  • Market cap (USD)
    3,537.14M
  • Shares
    117.98M

Business Summary

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others. The company was founded by Anmin Yamada on February 22, 1899 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2018 JPYUSD
Revenue171,795M1,550.04M
Gross Profit99,771M900.19M
Operating income18,755M169.21M
Income before tax16,820M151.76M
Net income9,289M83.81M
EBITDA24,669M222.57M
Diluted EPS81.200.73
Dividends Per Share220.19
Total Assets200,836M1,888.44M
Total liabilities72,393M680.70M
Total equity127,685M1,200.61M
Operating cash flow19,154M172.81M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 143,822M 151,774M 167,016M 154,599M 171,795M
Gross Profit 84,826M 89,075M 98,300M 90,012M 99,771M
Operating income 16,821M 13,159M 15,683M 15,452M 18,755M
Income before tax 14,599M 13,751M 14,303M 14,752M 16,820M
Net income 8,947M 8,631M 9,098M 10,011M 9,289M
EBITDA 22,747M 19,500M 22,131M 21,375M 24,669M
Diluted EPS 76.82 75.73 79.69 87.57 81.20
Dividends Per Share 18 19 20 21 22
Total Assets 162,249M 177,509M 179,573M 181,543M 200,836M
Total liabilities 63,622M 66,993M 68,302M 63,145M 72,393M
Total equity 98,248M 110,091M 110,809M 118,002M 127,685M
Operating cash flow 18,661M 11,292M 11,324M 13,428M 19,154M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 1,435.75M 1,381.56M 1,390.82M 1,427.67M 1,550.04M
Gross Profit 846.80M 810.83M 818.59M 831.23M 900.19M
Operating income 167.92M 119.78M 130.59M 142.69M 169.21M
Income before tax 145.74M 125.17M 119.10M 136.22M 151.76M
Net income 89.31M 78.56M 75.76M 92.44M 83.81M
EBITDA 227.08M 177.50M 184.29M 197.39M 222.57M
Diluted EPS 0.76 0.68 0.66 0.80 0.73
Dividends Per Share 0.17 0.17 0.16 0.19 0.19
Total Assets 1,575.46M 1,480.16M 1,597.69M 1,629.21M 1,888.44M
Total liabilities 617.77M 558.62M 607.69M 566.67M 680.70M
Total equity 954.00M 917.99M 985.88M 1,058.97M 1,200.61M
Operating cash flow 186.29M 102.78M 94.30M 124.00M 172.81M

Valuation Measures

Mar 2018
PER36.48
ROA4.85%
ROE7.56%
Operating margin10.91%
Profit margin5.40%

Key executives

  • Chairman & Chief Executive Officer: Kunio Yamada
  • President, COO & Representative Director: Toshiaki Yoshino
  • Manager-Finance & Accounting: Motohide Arai
  • Director & Vice President: Masaya Saito
  • Director, Chief Health Officer & Vice President: Lekh Raj Juneja

Shareholders

  • SPARX Asset Management Co., Ltd. (5.6%)
  • MFS International (UK) Ltd. (5.2%)
  • Mitsubishi UFJ Financial Group, Inc. (4.2%)
  • Rohto Pharmaceutical Co., Ltd. (3.4%)
  • YAMADA KIYOKO (2.5%)
  • Sansho Kosan KK (2.2%)
  • The Vanguard Group, Inc. (2.0%)
  • Nippon Life Insurance Co. (1.7%)
  • YAMADA FAMILY /ROHTO PHARMACEUTICAL/ (1.7%)
  • Nomura Asset Management Co., Ltd. (1.7%)

Contact Details

  • Website:http://www.rohto.co.jp
  • Address: 1-8-1 Tatsumi-nishi, Ikuno-Ku, Osaka, 544-8666, Japan
  • Phone: +81.6.6758.1231

Related Companies

  • Ophthalmos SA
  • A.J. North (Pty) Ltd.
  • Mayado Pharmaceutical Co., Ltd.
  • Episteme Trading (Shanghai) Co. Ltd.
  • Mentholatum (Asia Pacific) Ltd.
  • Mentholatum (China) Pharmaceuticals Co. Ltd.
  • Rohto Asia Herb (Thailand) Co. Ltd.
  • Mentholatum de Mexico SA de CV
  • Mentholatum Taiwan Ltd.
  • Mentholatum Australasia Pty Ltd.
  • Rohto-Mentholatum (Bangladesh) Ltd.
  • Rohto-Mentholatum (Malaysia) Sdn. Bhd.
  • Rohto-Mentholatum Thailand Ltd.
  • Rohto Pharma (India) Pvt Ltd.
  • Tianjin Rohto Herbal Medicine Co., Ltd.
  • Rohto Pharmaceutical Employee Incentive Plan
  • Hokushinfoods Co., Ltd.
  • Rohto Pharmaceutical Employee Stock Ownership Plan
  • Rohto-Mentholatum (Vietnam) Co., Ltd.
  • Medi Care Systems Co. Ltd.
  • Megro Chemical Industry Co. Ltd.
  • Mentholatum Co. Ltd.
  • Qualitech Pharma Co., Ltd.
  • Agera Laboratories, Inc.
  • Mentholatum Co., Inc.
  • MG Pharma

Competitors

    Last Updated on 17 Dec, 2018

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

    Stay ahead with our exclusives on Asia;
    the most dynamic market in the world.

    Stay ahead with our exclusives on Asia

    Get trusted insights from experts within Asia itself.

    Get trusted insights from experts
    within Asia itself.

    Get Unlimited access

    {{sentenceStarter}} {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} this month

    Stay ahead with our exclusives on Asia; the most dynamic market in the world.

    Benefit from in-depth journalism from trusted experts within Asia itself.

    Try 3 months for $9

    Offer ends September 30th

    Your trial period has expired

    You need a subscription to...

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers and subscribe

    Your full access to the Nikkei Asian Review has expired

    You need a subscription to:

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers
    NAR on print phone, device, and tablet media